Researchers found that patients taking suvorexant had reduced levels of amyloid beta and tau phosphorylation, proteins that play a major role in neurodegeneration in Alzheimer disease.
Can a dietary intervention known for reducing cardiovascular risk factors prevent cognitive decline in healthy older individuals? A team of researchers explored this question in a recent study.
This COVID-19 roundup includes a summary of studies on the effective treatment options for patients with long COVID, the risk of patients developing medical or mental health conditions post-hospitalization...
Researchers investigated the association and the potential sex differences between hypertension and blood pressure in early adulthood (ages 30-40 years) with late-life brain health.
Following two 12-week studies, the FDA has approved the first ever medication for treating agitation in patients with dementia due to Alzheimer disease.
A group of researchers aimed to determine the incidence rate of brain metastases in patients with metastatic uveal melanoma using data from comprehensive cancer centers.
Women with breast cancer who are receiving dose-dense paclitaxel are more likely to experience paclitaxel-induced peripheral neuropathy (PIPN) when compared with women who receive the treatment weekly,...
The FDA has approved a treatment for Friedreich ataxia after the results of randomized, placebo-controlled study indicate a strong effectiveness in treatment.
